-
Mashup Score: 0Zimbabwe’s battle to control a skin-burrowing worm faces a new challenge: climate change - 4 month(s) ago
Bilharzia, a parasitic worm that uses snails as a vector, is endemic to Zimbabwe, and could get more difficult to manage as weather patterns and temperatures shift, experts say.
Source: www.gavi.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
With more infants starting life in touch with the health system, can childhood immunisation rates expect a boost?
Source: www.gavi.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3
Micro Array Patches deliver vaccines without syringes, making them easier to distribute and administer. VaccinesWork asked the Developing Country Vaccine Manufacturers’ Network (DCVMN), a group representing manufacturers across the Global South, how they could make a difference in lower-income countries worldwide.
Source: www.gavi.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2
Micro Array Patches deliver vaccines without syringes, making them easier to distribute and administer. VaccinesWork asked the Developing Country Vaccine Manufacturers’ Network (DCVMN), a group representing manufacturers across the Global South, how they could make a difference in lower-income countries worldwide.
Source: www.gavi.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 218 million doses of first-ever malaria vaccine allocated to 12 African countries for 2023–2025: Gavi, WHO and UNICEF - 10 month(s) ago
Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years.
Source: www.gavi.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Global Vaccine Alliance to deploy six-in-one vaccine to lower-income countries, establish innovative mechanisms to protect against future epidemic threats - 11 month(s) ago
Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today
Source: www.gavi.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Global Vaccine Alliance to deploy six-in-one vaccine to lower-income countries, establish innovative mechanisms to protect against future epidemic threats - 11 month(s) ago
Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today
Source: www.gavi.orgCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 45Five things you need to know about the new R21 malaria vaccine - 11 month(s) ago
Ghana is the first country to approve a new malaria vaccine that could save millions of lives in the world’s most malaria-ridden regions. Here are five things you need to know about the new vaccine.
Source: www.gavi.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1David Marlow to Become Interim Chief Executive Officer of Gavi - 11 month(s) ago
The Gavi Board decided today to appoint David Marlow, currently Gavi`s Chief Operating Officer, to the position of Interim Chief Executive Officer, effective 3 August 2023.
Source: www.gavi.orgCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2Goodbye syringe? Measles and rubella patch demonstrates its worth in Gambia vaccine trial - 12 month(s) ago
Painless, easier to administer and more thermostable than traditional vaccines, microarray patches are being touted as the future of vaccination in low-income and pandemic settings.
Source: www.gavi.orgCategories: Infectious Disease, Latest HeadlinesTweet
Zimbabwe’s battle to control a skin-burrowing worm faces a new challenge: climate change - “the suspected link between climate change and bilharzia rates moves in both directions” https://t.co/tOOI0rvo2U